Freenome lands $270m Series C
South San Francisco-based Freenome, a provider of a multiomics platform for early cancer detection, has raised $270 million in Series C funding.
South San Francisco-based Freenome, a provider of a multiomics platform for early cancer detection, has raised $270 million in Series C funding.
Copyright PEI Media
Not for publication, email or dissemination